Email Alert | RSS

Journal of Peking University (Health Sciences) ›› 2025, Vol. 57 ›› Issue (5): 864-867. doi: 10.19723/j.issn.1671-167X.2025.05.009

Previous Articles     Next Articles

Development and dissemination of precision medicine approaches in gastric cancer management

Zhemin LI1, Jiafu JI2,*(), Guoxin LI3, Ziyu LI1, Zhaode BU1, Xiangyu GAO2, Di DONG4, Lei TANG5, Xiaofang XING6, Shuqin JIA7, Ting GUO8, Lianhai ZHANG1, Fei SHAN1, Xin JI1, Anqiang WANG1   

  1. 1. Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing 100142, China
    2. Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing 100142, China
    3. Department of Gastrointestinal Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing 102218, China
    4. CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing 100190, China
    5. Department of Medical Imaging, Peking University Cancer Hospital & Institute, Beijing 100142, China
    6. Gastrointestinal Cancer Translational Research Laboratory, Peking University Cancer Hospital & Institute, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing 100142, China
    7. Molecular Diagnostic Center, Peking University Cancer Hospital & Institute, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing 100142, China
    8. Gastrointestinal Cancer Translational Research Laboratory, Peking University Cancer Hospital & Institute, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing 100142, China
  • Received:2025-08-01 Online:2025-10-18 Published:2025-08-28
  • Contact: Jiafu JI
  • Supported by:
    the National Natural Science Foundation(92259302); the National Natural Science Foundation(31870805); the National Natural Science Foundation(U20A20371); the Beijing Hospitals Authority Talent Plan(DFL20181103); the Beijing Hospitals Authority Talent Plan(SML20151001); the Beijing Municipal Science and Technology Plan Projects(D171100006517000); the Beijing Municipal Science and Technology Plan Projects(D171100006517004)

RICH HTML

   

PDF (PC)

Abstract: Gastric cancer is a high-incidence malignancy that poses a serious threat to public health in China, ranking among the top three cancers in both incidence and mortality. The majority of patients are diagnosed at an advanced stage, resulting in limited treatment options and poor prognosis. To address key challenges in gastric cancer diagnosis and treatment, a research team led by Professor Jiafu Ji at Peking University Cancer Hospital has focused on the project "Development and Dissemination of Precision Medicine Approaches in Gastric Cancer Management". Through a series of high-quality multicenter clinical studies, the team established a set of new international standards in perioperative treatment, individua-lized drug selection, intelligent noninvasive diagnostics, and novel immunotherapy strategies. These advances have significantly improved treatment efficacy and reduced surgical trauma, achieving key technological breakthroughs in diagnosis, therapy, and mechanistic understanding, and systematically enhancing outcomes for gastric cancer patients. The project ' s findings had a broad international impact, including hosting China ' s first International Gastric Cancer Congress. Through nationwide dissemination, they have promoted the development of precision diagnosis and treatment of gastric cancer as a discipline, and led the formulation of the National Health Commission's guidelines for gastric cancer diagnosis and treatment. In recognition of its achievements, the project was awarded the First Prize of the 2024 Chinese Medical Science and Technology Award.

Key words: Gastric cancer, Neoadjuvant chemotherapy, Laparoscopic surgery, Artificial intelligence, Immunotherapy

CLC Number: 

  • R735.2
1
Yang L, Zheng R, Wang N, et al. Incidence and mortality of stomach cancer in China, 2014[J]. Chin J Cancer Res, 2018, 30(3): 291- 298.
2
Sano T, Coit DG, Kim HH, et al. Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project[J]. Gastric Cancer, 2017, 20(2): 217- 225.

doi: 10.1007/s10120-016-0601-9
3
Bang YJ, Kim YW, Yang HK, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): A phase 3 open-label, randomised controlled trial[J]. Lancet, 2012, 379(9813): 315- 321.
4
Bang YJ, van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial[J]. Lancet, 2010, 376(9742): 687- 697.
5
Zhang X, Liang H, Li Z, et al. Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): An open-label, superiority and non-inferiority, phase 3 randomised controlled trial[J]. Lancet Oncol, 2021, 22(8): 1081- 1092.

doi: 10.1016/S1470-2045(21)00297-7
6
Japanese Gastric Cancer Association. Japanese Gastric Cancer Treatment Guidelines 2021(6th edition)[J]. Gastric Cancer, 2023, 26(1): 1- 25.

doi: 10.1007/s10120-022-01331-8
7
Kim IH, Kang SJ, Choi W, et al. Korean practice guidelines for gastric cancer 2024:An evidence-based, multidisciplinary approach (update of 2022 guideline)[J]. J Gastric Cancer, 2025, 25(1): 5- 114.

doi: 10.5230/jgc.2025.25.e11
8
Yin S, Xi R, Wu A, et al. Patient-derived tumor-like cell clusters for drug testing in cancer therapy[J]. Sci Transl Med, 2020, 12(549): eaaz1723.
9
Li Z, Gao X, Peng X, et al. Multi-omics characterization of molecular features of gastric cancer correlated with response to neoadjuvant chemotherapy[J]. Sci Adv, 2020, 6(9): eaay4211.
10
Yu J, Huang C, Sun Y, et al. Effect of laparoscopic vs open distal gastrectomy on 3-year disease-free survival in patients with locally advanced gastric cancer: The CLASS-01 randomized clinical trial[J]. JAMA, 2019, 321(20): 1983- 1992.
11
Li Z, Shan F, Ying X, et al. Assessment of laparoscopic distal gastrectomy after neoadjuvant chemotherapy for locally advanced gastric cancer: A randomized clinical trial[J]. JAMA Surg, 2019, 154(12): 1093- 1101.

doi: 10.1001/jamasurg.2019.3473
12
Li Z, Li Z, Jia S, et al. Depth of tumor invasion and tumor-occupied portions of stomach are predictive factors of intra-abdominal metastasis[J]. Chin J Cancer Res, 2017, 29(2): 109- 117.

doi: 10.21147/j.issn.1000-9604.2017.02.03
13
Dong D, Tang L, Li ZY, et al. Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer[J]. Ann Oncol, 2019, 30(3): 431- 438.

doi: 10.1093/annonc/mdz001
14
Dong D, Fang MJ, Tang L, et al. Deep learning radiomic nomogram can predict the number of lymph node metastasis in locally advanced gastric cancer: An international multicenter study[J]. Ann Oncol, 2020, 31(7): 912- 920.

doi: 10.1016/j.annonc.2020.04.003
15
Xing X, Jia S, Leng Y, et al. An integrated classifier improves prognostic accuracy in non-metastatic gastric cancer[J]. Oncoimmunology, 2020, 9(1): 1792038.
16
Guo T, Tang XH, Gao XY, et al. A liquid biopsy signature of circulating exosome-derived mRNAs, miRNAs and lncRNAs predict therapeutic efficacy to neoadjuvant chemotherapy in patients with advanced gastric cancer[J]. Mol Cancer, 2022, 21(1): 216.

doi: 10.1186/s12943-022-01684-9
17
Ma X, Jia S, Wang G, et al. TRIM28 promotes the escape of gastric cancer cells from immune surveillance by increasing PD-L1 abundance[J]. Signal Transduct Target Ther, 2023, 8(1): 246.

doi: 10.1038/s41392-023-01450-3
18
Yu H, Wang M, Zhang T, et al. Dual roles of β-arrestin 1 in mediating cell metabolism and proliferation in gastric cancer[J]. Proc Natl Acad Sci USA, 2022, 119(40): e2123231119.

doi: 10.1073/pnas.2123231119
19
Guo T, Bai YH, Cheng XJ, et al. Insulin gene enhancer protein 1 mediates glycolysis and tumorigenesis of gastric cancer through regulating glucose transporter 4[J]. Cancer Commun (Lond), 2021, 41(3): 258- 272.
20
Guan X, Cai M, Du Y, et al. CVCDAP: An integrated platform for molecular and clinical analysis of cancer virtual cohorts[J]. Nucleic Acids Res, 2020, 48(W1): W463- W471.
[1] Zhaode BU, Mengyu FENG, Ke JI. Practice and reflection on sentinel lymph node navigation surgery for early gastric cancer [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 239-243.
[2] Jiafu JI, Jingtao WEI, Ke JI, Zhaode BU. Bottlenecks and breakthroughs in gastric cancer diagnosis and treatment: Towards a new era of precision and intelligent integration [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 231-238.
[3] Jiale GAO, Zhongtao ZHANG. Current status and future perspectives of precision treatment for locally advanced rectal cancer [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 247-250.
[4] Bixian LUO, Hongming LIU, Weixun XIE, Weihua GONG. Novel clinical insights and frontier issues in alpha- fetoprotein-producing gastric cancer [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 257-265.
[5] Hao FU, Luyan SHEN, Bingyang HUANG, Shaohua MA. Clinical strategies for perioperative management of esophageal squamous cell carcinoma in the immunotherapy era [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 266-271.
[6] Wen DU, Wenbo ZHANG, Yao YU, Shuo LIU, Huiyu SU, Leihao HU, Zunan TANG, Binzhang WU, Zhen CHEN, Jiaqi LI, Hao WANG, Xin PENG. Exploration and clinical application of the "digital and intelligent surgery" diagnosis and treatment workflow for oral and maxillofacial tumors [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 278-284.
[7] Zichen PAN, Kai CHEN, Yukun HOU, Bohan YANG, Jixin ZHANG, Yongsu MA, Xiaodong TIAN, Yinmo YANG. Research progress in clinical pathology and molecular mechanisms of pancreatic adenosquamous carcinoma [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 431-435.
[8] Wanwei HUANG, Xianshen SHA, Yibao ZHANG, Guohao WU, Feng LUO, Zhihui CHEN, Dongming YE, Xuesong LI, Caiyong LAI. Total 3D laparoscopic ileal ureters replacement for bilateral ureters combined with bladder augmentation in the management of post-radiotherapy bilateral ureteral strictures and contracted bladder [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 789-795.
[9] Miaoyu LIU, Siyuan WANG, Lin PEI, Shu WANG. Impact of concurrent use of goserelin on the efficacy of neoadjuvant chemotherapy in young breast cancer patients [J]. Journal of Peking University (Health Sciences), 2025, 57(2): 291-297.
[10] Xuejun LIANG, Fengxia ZHANG, Ting JIN, Jingjing ZHU. Biological activity and antitumor effect of long-acting recombinant human interleukin-2 drug [J]. Journal of Peking University (Health Sciences), 2025, 57(2): 253-261.
[11] Jiajun LIU, Guokang LIU, Yuhu ZHU. Immune-related severe pneumonia: A case report [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 932-937.
[12] Hai MAO,Fan ZHANG,Zhan-yi ZHANG,Ye YAN,Yi-chang HAO,Yi HUANG,Lu-lin MA,Hong-ling CHU,Shu-dong ZHANG. Predictive model of early urinary continence recovery based on prostate gland MRI parameters after laparoscopic radical prostatectomy [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 818-824.
[13] Xiang LIU,Hui-hui XIE,Yu-feng XU,Xiao-dong ZHANG,Xiao-feng TAO,Lin LIU,Xiao-ying WANG. Value of artificial intelligence in the improvement of diagnostic consistency of radiology residents [J]. Journal of Peking University (Health Sciences), 2023, 55(4): 670-675.
[14] Ju-mei LIU,Li LIANG,Ji-xin ZHANG,Long RONG,Zi-yi ZHANG,You WU,Xu-dong ZHAO,Ting LI. Pathological evaluation of endoscopic submucosal dissection for early gastric cancer and precancerous lesion in 411 cases [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 299-307.
[15] SUN Yu-chun,GUO Yu-qing,CHEN Hu,DENG Ke-hui,LI Wei-wei. Independent innovation research, development and transformation of precise bionic repair technology for oral prosthesis [J]. Journal of Peking University (Health Sciences), 2022, 54(1): 7-12.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd